» Articles » PMID: 33609308

County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2021 Feb 20
PMID 33609308
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Since 2013, the national hepatitis C virus (HCV) death rate has steadily declined, but this decline has not been quantified or described on a local level.

Approach And Results: We estimated county-level HCV death rates and assessed trends in HCV mortality from 2005 to 2013 and from 2013 to 2017. We used mortality data from the National Vital Statistics System and used a Bayesian multivariate space-time conditional autoregressive model to estimate age-standardized HCV death rates from 2005 through 2017 for 3,115 U.S. counties. Additionally, we estimated county-level, age-standardized rates for persons <40 and 40+ years of age. We used log-linear regression models to estimate the average annual percent change in HCV mortality during periods of interest and compared county-level trends with national trends. Nationally, the age-adjusted HCV death rate peaked in 2013 at 5.20 HCV deaths per 100,000 persons (95% credible interval [CI], 5.12, 5.26) before decreasing to 4.34 per 100,000 persons (95% CI, 4.28, 4.41) in 2017 (average annual percent change = -4.69; 95% CI, -5.01, -4.33). County-level rates revealed heterogeneity in HCV mortality (2017 median rate = 3.6; interdecile range, 2.19, 6.77), with the highest rates being concentrated in the West, Southwest, Appalachia, and northern Florida. Between 2013 and 2017, HCV mortality decreased in 80.0% (n = 2,274) of all U.S. counties with a reliable trend estimate, with 25.8% (n = 803) of all counties experiencing a decrease larger than the national decline.

Conclusions: Although many counties have experienced a shift in HCV mortality trends since 2013, the magnitude and composition of that shift have varied by place. These data provide a better understanding of geographic differences in HCV mortality and can be used by local jurisdictions to evaluate HCV mortality in their areas relative to surrounding areas and the nation.

Citing Articles

Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses.

Gizamba J, Finch B, Wang S, Klausner J BMC Public Health. 2025; 25(1):687.

PMID: 39972312 PMC: 11841175. DOI: 10.1186/s12889-025-21668-w.


Human Riboviruses: A Comprehensive Study.

Mohan G, Choudhury A, Bhat J, Phartyal R, Lal R, Verma M J Mol Evol. 2024; 93(1):11-37.

PMID: 39739017 DOI: 10.1007/s00239-024-10221-9.


Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study.

Bredenberg E, Callister C, Dafoe A, Holliman B, Rowan S, Calcaterra S Harm Reduct J. 2024; 21(1):140.

PMID: 39054530 PMC: 11271208. DOI: 10.1186/s12954-024-01057-z.


Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data.

Hall E, Sullivan P, Bradley H JMIR Public Health Surveill. 2024; 10:e49527.

PMID: 38578676 PMC: 11031697. DOI: 10.2196/49527.


Changing Epidemiological Patterns of Infection and Mortality Due to Hepatitis C Virus in Poland.

Genowska A, Zarebska-Michaluk D, Strukcinskiene B, Razbadauskas A, Moniuszko-Malinowska A, Jurgaitis J J Clin Med. 2023; 12(12).

PMID: 37373617 PMC: 10299469. DOI: 10.3390/jcm12123922.


References
1.
Jones C, Flower B, Barber E, Simmons B, Cooke G . Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis. Wellcome Open Res. 2019; 4:132. PMC: 6854875. DOI: 10.12688/wellcomeopenres.15411.1. View

2.
Ly K, Minino A, Liu S, Roberts H, Hughes E, Ward J . Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016-2017. Clin Infect Dis. 2019; 71(5):1149-1160. PMC: 11089524. DOI: 10.1093/cid/ciz976. View

3.
Bradley H, Hall E, Rosenthal E, Sullivan P, Ryerson A, Rosenberg E . Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016. Hepatol Commun. 2020; 4(3):355-370. PMC: 7049678. DOI: 10.1002/hep4.1457. View

4.
Ryerson A, Schillie S, Barker L, Kupronis B, Wester C . Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018. MMWR Morb Mortal Wkly Rep. 2020; 69(14):399-404. PMC: 7147907. DOI: 10.15585/mmwr.mm6914a2. View

5.
Vaughan A, Schieb L, Casper M . Historic and recent trends in county-level coronary heart disease death rates by race, gender, and age group, United States, 1979-2017. PLoS One. 2020; 15(7):e0235839. PMC: 7340306. DOI: 10.1371/journal.pone.0235839. View